| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/03/2007 | EP1304371B1 Cds1 knockout mice and cell lines established thereof |
| 01/03/2007 | EP1280890B1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1221865B1 Food supplement for increasing lean mass and strength |
| 01/03/2007 | EP1192184B1 Surfactant protein c esters |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP1093379B1 Use of inhibitors of protein kinase c epsilon to treat pain |
| 01/03/2007 | EP1057489B1 Use of midkine family proteins in the treatment of ischemic diseases |
| 01/03/2007 | EP1044014B9 Agent for treating allergic or hypersensitivity condition |
| 01/03/2007 | EP0942996B1 Thrombolytic agents with antithrombotic activity |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0871474B1 Generation of human insulin |
| 01/03/2007 | EP0865295B1 Use of human chorionic gonadotropin in the treatment of kaposi's sarcoma |
| 01/03/2007 | EP0776361B1 Recombinant herpesvirus of turkeys and uses thereof |
| 01/03/2007 | EP0771213B1 Haemophilus influenzae adherence and penetration proteins |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | EP0669929B1 Elk ligand, a cytokine |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890567A Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 01/03/2007 | CN1890371A Muteins of fibroblast growth factor 21 |
| 01/03/2007 | CN1890264A Gag binding proteins |
| 01/03/2007 | CN1890262A Method of producing antithrombin iii composition |
| 01/03/2007 | CN1890215A Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 01/03/2007 | CN1889974A Oligopeptides as coating material for medical products |
| 01/03/2007 | CN1889973A Use of LIMK-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease |
| 01/03/2007 | CN1889972A Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
| 01/03/2007 | CN1889971A Pharmaceutical formulations for the sustained release of interferons and therapeutic applications thereof |
| 01/03/2007 | CN1889970A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication |
| 01/03/2007 | CN1889956A Methods and reagents for the treatment of immunoinflammatory disorders |
| 01/03/2007 | CN1889856A Nutritional composition against side effects of chemotherapy of radiotherapy |
| 01/03/2007 | CN1887906A Hypoglycemic polypeptide from silkworm and its prepn and use |
| 01/03/2007 | CN1887901A Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit |
| 01/03/2007 | CN1887349A Helicobacter pylori vaccine based on urease B subunit active segment and its prepn process |
| 01/03/2007 | CN1887347A Prepn technology of antithrombotic hirudin aerosol |
| 01/03/2007 | CN1887346A Recombinant human interferon-alpha-thymulin medicine composition and its applied prepn form |
| 01/03/2007 | CN1887345A Immunopotentiator for treating hepatitis B |
| 01/03/2007 | CN1887344A Animal interferon compound and its prepn and application |
| 01/03/2007 | CN1887343A Application of cell factor in resisting tuberculosis infection |
| 01/03/2007 | CN1887342A Medicine prepn for treating cow's mammitis and its prepn and use |
| 01/03/2007 | CN1887274A Prepn process of slow released microsphere of protein-polysaccharide vitreous particle |
| 01/03/2007 | CN1293193C Gene clone of and expression Japan lamprey oral cavity gland KGD model protein possessing anti thrombotic action |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1293098C Concatameric immunoadhesion |
| 01/03/2007 | CN1293096C Method for synthesis of analogs of parathyroid hormone and parathyroid hormone related peptide |
| 01/03/2007 | CN1292797C Immune regulator, immune regulator food and immune regulator fodder |
| 01/03/2007 | CN1292796C Controlled release composition and method of producing the same |
| 01/03/2007 | CN1292793C Application of kininogenase of human urine in preparing medication for treating pyemia |
| 01/03/2007 | CN1292745C The treatment of respiratory diseases |
| 01/03/2007 | CN1292655C Stable liquid pharmaceutical formulation of IgG antibodies |
| 01/02/2007 | US7157596 Inhibitors of serine protease activity of matriptase or MTSP1 |
| 01/02/2007 | US7157570 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157559 Homogeneous preparations of IL-28 and IL-29 |
| 01/02/2007 | US7157558 Polypeptide encoded by a polynucleotide overexpresses in tumors |
| 01/02/2007 | US7157557 Generation of preferential genetically engineered protein; obtain cells, transform with vector containing protein, express vector, recover protein |
| 01/02/2007 | US7157556 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use |
| 01/02/2007 | US7157555 A polypeptide useful in the treatment of Type I and II diabetes; delaying and/or slowing gastric emptying; lowering plasma glucose levels |
| 01/02/2007 | US7157554 Forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent containing a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide |
| 01/02/2007 | US7157553 A peptide substrate for use as site of botulinum or tetnaus neurotoxin protease action and in identifying modulator which inhibit neurotoxic activity; prevention and treatment of food poisoning; fluorescence resonant energy transfer assay |
| 01/02/2007 | US7157552 Mutant trichosanthin |
| 01/02/2007 | US7157546 Water-soluble polymer alkanals |
| 01/02/2007 | US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |
| 01/02/2007 | US7157438 Rhob as a suppressor of cancer cell growth and cell transformation |
| 01/02/2007 | US7157436 An specific oligonucleotide sequence conataining 2-20 base 3'OH, 5'OH synthetic oligonucleotide which induces a response selected from cell cycle arrest, inhibition of cell proliferation, activation of caspases in cancer cells |
| 01/02/2007 | US7157435 Delivering a dosage of a growth factor-encoding transgene composition to preselected delivery sites in the brain where the encoded growth factor is expressed and stimulates axonal growth; mimimally invasive; Alzheimer's, Parkinson diseases |
| 01/02/2007 | US7157429 Method of regulating glucose metabolism, and reagents related thereto |
| 01/02/2007 | US7157428 Introducing into a site of the meniscus injury, lesion or tear an adhesive rapidly gelling biodegradable derivatized collagen-PEG hydrogel complex wherein said derivatized collagen is alkylated Type I collagen |
| 01/02/2007 | US7157427 Inhibitiing bacterial infection in a mammal wherein infection is caused by Bacillus or Escheria bacterium by administering a protein |
| 01/02/2007 | US7157426 such as peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), and polyol such as sucrose |
| 01/02/2007 | US7157425 Apolipoprotein agonist for use in the treatment of dyslipidemia |
| 01/02/2007 | US7157424 mistures of quinolinyloxy-substituted cyclic peptides containing fused cyclopropyl and pyrrolidine rings, an amine (especially tris(hydroxymethyl)aminomethane) and a base that inhibit hepatitis C viral protease |
| 01/02/2007 | US7157423 Using fumaric acid mono- and diamides, or monoamido fumaric acid monoesters for therapy of an autoimmune disease; transplantation medicine; therapy of mitochondrial diseases, for therapy of NF-kappaB mediated diseases |
| 01/02/2007 | US7157422 Glycogen synthase kinase-3 inhibitors |
| 01/02/2007 | US7157420 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 01/02/2007 | US7157419 Growth factor binding molecules |
| 01/02/2007 | US7157277 Factor VIII remodeling and glycoconjugation of Factor VIII |
| 01/02/2007 | US7157275 growing adherent cells using a cell adhesion promoting ("CAP") peptide covalently coupled to a cell adhesion resistant layer such as hyaluronic acid on a polystyrene surface to promote cell attachment, growth differentiation, in culture; biological scaffolds |
| 01/02/2007 | US7157264 Generation of adjusted enzyme; obtain target enzyme, analyze to determine active site, adjust amino acid sequence in active site, recover enzyme with adjusted activity |
| 01/02/2007 | US7157259 Murine lecithin-cholesterol acyltransferase protein |
| 01/02/2007 | US7157250 Glutamic acid receptor and utilization thereof |
| 01/02/2007 | US7157247 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/02/2007 | US7157246 RNA polymerase I transcription factor TIF-IA |
| 01/02/2007 | US7157245 Neisserial vaccine compositions and methods |
| 01/02/2007 | US7157243 DNA encoding mammalian T-type calcium channels |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157099 Stable, biologically compatible pharmaceutical compositions in the form of water-in-oil microemulsions (w/o), for the sustained release by parenteral administration of active ingredients which are hydrophilic or are made hydrophilic by |
| 01/02/2007 | US7157091 Endosomal targeting signal contains an endosomal targeting portion of human invariant chain Ii or LAMP-1. |
| 01/02/2007 | US7157089 A fusion protein containing an antigen of an influenza virus and a bacterial stress protein; vaccines induce a cytolytic T-cell (CTL) response in a mammal |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157084 Extracellular serine protease |
| 01/02/2007 | US7157083 Aid therapy |
| 01/02/2007 | US7157082 Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase |
| 01/02/2007 | US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 01/02/2007 | US7157080 Injectable hyaluronic acid derivative with pharmaceuticals/cells |
| 01/02/2007 | US7157079 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |